The main purpose of this legislation is to provide a specific treatment option, known as stellate ganglion block, to veterans and active members of the Armed Forces who are diagnosed with post-traumatic stress disorder (PTSD). The goal is to improve access to this therapy, which may help alleviate symptoms of PTSD. Key provisions of the law include the requirement for the Secretary of Veterans Affairs and the Secretary of Defense to offer stellate ganglion block to veterans and service members who meet certain criteria.